Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib

Conditions: Advanced ALK/ROS1-positive NSCLC; Carcinoma, Non-Small-Cell Lung (NSCLC); Lung Adenocarcinoma; ALK-positive Non-small Cell Lung Cancer (NSCLC); Cognitive Dysfunction; Depression

Sponsors: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo

Recruiting